Search clinical trials for: AMG 655

Total 1915 results

Amgen

Completed

Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

Kidney Disease
Amgen

Completed

Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis

Anemia | Chronic Renal Failure
Amgen

Completed

A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa

Small Cell Lung Cancer
Amgen

Completed

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Breast Cancer | Neutropenia | Fever
Amgen

Terminated

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

Chronic Kidney Disease
Society for Applied Studies
All India Institute of Medical Sciences, New Delhi; National Institutes of... and other collaborators

Completed

Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants

Rotavirus Infections

India
Amgen

Completed

Treatment for Patients With Osteoarthritis (OA)

Osteoarthritis
Amgen

Completed

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

Kidney Disease
University Hospital, Clermont-Ferrand
Amgen

Terminated

Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

Solid Malignancies
Massachusetts General Hospital
Amgen

Completed

Study of TNF-Antagonism in Metabolic Syndrome

Metabolic Syndrome

United States
Medical University of Gdansk

Completed

Desflurane Versus Propofol Anesthesia for Off-Pump CABG

Coronary Artery Disease

Poland
Amgen

Completed

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
Amgen

Completed

Treatment for Elderly Patients With High Risk Breast Cancer

Breast Cancer
Amgen

Completed

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

Kidney Disease
Rigshospitalet, Denmark

Completed

Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents

Neuromuscular Blockade

Denmark
Rigshospitalet, Denmark

Completed

Performance of Acceleromyography With and Without Preload

Neuromuscular Blockade

Denmark
Amgen

Completed

Ancillary Study to Protocol 20060104

Rheumatoid Arthritis
National Cancer Institute (NCI)

Completed

Combination Drug Treatment of Pediatric HIV Infection

HIV Infection

United States
Amgen

Completed

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

Anemia | Kidney Disease
Amgen

Completed

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Cancer | Non-Myeloid Malignancies
Amgen

Completed

Pegfilgrastim PBPC Mobilization Study

Lymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Oncology | Hematology
Amgen

Completed

Treatment for Patients With Osteoarthritis (OA) of the Knee

Osteoarthritis
Amgen

Completed

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease
NSABP Foundation Inc
Amgen

Withdrawn

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Neoplasm Metastasis | Rectal Cancer
Amgen

Completed

Post Transplant Study

Hyperparathyroidism | Secondary Hyperparathyroidism | Kidney Tansplant
Amgen

Completed

Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects

Anemia
Amgen

Completed

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Non-Hodgkin's Lymphoma
National Institute of Arthritis and Musculoskeletal...
University of Pittsburgh; Genzyme, a Sanofi Company; Amgen

Terminated

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

Systemic Sclerosis | Scleroderma

United States
Amgen

Completed

Phase 2 AMG 714 in Rheumatoid Arthritis

Rheumatoid Arthritis
Amgen

Completed

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Nephrology
Amgen

Completed

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

Anemia
Amgen

Completed

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Anemia | Non-Small Cell Lung Cancer
Amgen

Completed

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Amgen

Completed

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Neoplasm Metastasis | Non-Small Cell Lung Cancer | Lung Cancer
Amgen

Completed

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Breast Cancer | Anemia
Amgen

Completed

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Genital Neoplasms, Female | Anemia | Gynecological Malignancies
Wyeth is now a wholly owned subsidiary of Pfizer
Amgen

Completed

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

Psoriasis

Belgium, France, Spain, Germany, Italy, Austria, Poland, Romania, Netherlands, Hungary
University of Washington
Amgen

Completed

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

Anemia | Prostate Cancer

United States
Heinrich-Heine University, Duesseldorf

Completed

Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis

Systemic Scleroderma | Skin Fibrosis | Hand Functionality

Germany
Heinrich-Heine University, Duesseldorf

Completed

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus

Germany
Heinrich-Heine University, Duesseldorf

Completed

Sunscreen RV 2457C in Photoinduced CLE

Skin Lesion | Cutaneous Lupus Erythematosus | Experimental Photoinduction | Protective Sunscreen

Germany
Community Cancer Care
Amgen

Unknown

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Cancer | Solid Tumor | Hematologic Malignancy

United States
Herning Hospital
Amgen

Completed

The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery

Colorectal Cancer

Denmark
University of Michigan
Amgen

Completed

Leptin and Endothelial Function

Healthy
Association Européenne de Recherche en Oncologie
Amgen; Aventis Pharmaceuticals

Completed

Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

Node Positive Breast Cancer
Amgen

Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

HIV Infections | Cytopenias

United States, Canada
Amgen

Completed

Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Amgen

Completed

The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS

HIV Infections

United States
Amgen

Completed

A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex

HIV Infections | Cytopenias

United States
Glaxo Wellcome

Unknown

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

HIV Infections

United States

3

Subscribe